MedPath

Sodium Fluoride F 18

These highlights do not include all the information needed to use Sodium Fluoride F 18 Injection USP safely and effectively. See full prescribing information for Sodium Fluoride F 18 Injection USP . SODIUM FLUORIDE F 18 INJECTION USP For Intravenous Use Initial U.S. Approval: xxxx

Approved
Approval ID

e435568c-f8d2-4cee-aceb-c68b277ad8f5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 4, 2023

Manufacturers
FDA

Mayo Clinic

DUNS: 167141923

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sodium fluoride F 18

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52670-550
Application NumberANDA203605
Product Classification
M
Marketing Category
C73584
G
Generic Name
sodium fluoride F 18
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 4, 2023
FDA Product Classification

INGREDIENTS (2)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM FLUORIDE F-18Active
Quantity: 91.5 mCi in 1 mL
Code: 9L75099X6R
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Fluoride F 18 - FDA Drug Approval Details